Top compounds associated with response to TAGLN3


Feature Type Standardized
Nominal ANOVA
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.19 5e-09
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.2 6e-09
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.19 1e-08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-08
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA apicidin CTRPv2 pan-cancer AAC 0.17 4e-08
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.24 5e-08
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.19 5e-08
Download CSV